Expertise in
23
conditions

Dr. Isaac Yeboah

Hematology | Oncology
Marshfield Medical Center-Marshfield Medical Offices Cancer Care
1000 N Oak Ave, 
Marshfield, WI 
Accepting New Patients
Expertise in
23
conditions
Marshfield Medical Center-Marshfield Medical Offices Cancer Care
1000 N Oak Ave, 
Marshfield, WI 

Overview

Isaac Yeboah is a Hematologist and an Oncologist practicing medicine in Marshfield, Wisconsin.

Dr. Yeboah is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Angiosarcoma, Bone Marrow Aspiration, and Gastrostomy.

He is actively involved in clinical research, participating in 5 clinical trials. Dr. Yeboah is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in WI

Hospital Affiliations

Marshfield Medical Center - Weston
Marshfield Medical Center
Marshfield Medical Center - Neillsville
Marshfield Medical Center - Eau Claire
Marshfield Medical Center - Minocqua

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Marshfield Medical Center-Marshfield Medical Offices Cancer Care
1000 N Oak Ave, Marshfield, WI 54449
Other Locations
Marshfield Medical Center-Wisconsin Rapids Campus (Clinic)-Cancer Care
220 24th St S, Wisconsin Rapids, WI 54494
Marshfield Clinic Marshfield Center
1000 N Oak Ave, Marshfield, WI 54449

Additional Areas of Focus

Dr. Yeboah has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Phase: Phase 3
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Suspended
Publish Date: September 01, 2026
Intervention Type: Biological, Drug, Procedure, Radiation
Study Drugs: Carboplatin, Ipilimumab, Nivolumab, Paclitaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Olaparib, Pembrolizumab
Study Phase: Phase 2
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
36
conditions
Dr. Niaz M. Haque
Hematology | Oncology
Expertise in
36
conditions
Dr. Niaz M. Haque
Hematology | Oncology
Referral may be required

Aspirus Regional Cancer Center

215 N 28th Ave, 
Wausau, WI 
 (40.2 miles away)
715-847-2866
Languages Spoken:
English, Bengali, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Niaz Haque is a Hematologist and an Oncologist practicing medicine in Wausau, Wisconsin. Dr. Haque is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Cervical Cancer, and Bone Marrow Aspiration. Dr. Haque is currently accepting new patients.

Expertise in
25
conditions
Dr. Seth Fagbemi
Hematology | Oncology
Expertise in
25
conditions
Dr. Seth Fagbemi
Hematology | Oncology
Referral may be required

Marshfield Clinic Marshfield Center

1000 N Oak Ave, 
Marshfield, WI 
 (27.3 miles away)
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Seth Fagbemi is a Hematologist and an Oncologist practicing medicine in Marshfield, Wisconsin. He has been practicing medicine for over 44 years. Dr. Fagbemi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Familial Colorectal Cancer, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Prostatectomy. Dr. Fagbemi is currently accepting new patients.

Expertise in
12
conditions
Dr. Hamid Emamekhoo
Oncology | Hematology Oncology | Hematology
Expertise in
12
conditions
Dr. Hamid Emamekhoo
Oncology | Hematology Oncology | Hematology
Referral may be required

University Of Wisconsin Medical Foundation Inc

1040 Division St, 
Mauston, WI 
 (44.0 miles away)
608-847-7355
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hamid Emamekhoo is an Oncologist and a Hematologist Oncology provider practicing medicine in Mauston, Wisconsin. Dr. Emamekhoo is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Tissue Biopsy. Dr. Emamekhoo is currently accepting new patients.

Frequently Asked Questions about Dr. Isaac Yeboah

How do I make an appointment with Dr. Isaac Yeboah?

You can book an appointment with Dr. Isaac Yeboah by calling their office at 715-387-5416. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Isaac Yeboah a top-rated expert for Clear Cell Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Isaac Yeboah is classified as an Distinguished expert for Clear Cell Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Isaac Yeboah specialize in?

While Dr. Isaac Yeboah is a Hematology, they have specific expertise in Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Isaac Yeboah accept my insurance?

Dr. Isaac Yeboah accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health Plan. We recommend calling the office directly at 715-387-5416 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yeboah's expertise for a condition
ConditionClose
    View All 21 Advanced Conditions
    View All 80 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile